Status:
COMPLETED
Rotavirus Efficacy and Safety Trial (REST)(V260-006)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rotavirus Infections
Eligibility:
All Genders
6-12 years
Phase:
PHASE3
Brief Summary
This study was designed to evaluate the safety of the investigational rotavirus vaccine and the efficacy to prevent rotavirus gastroenteritis.
Eligibility Criteria
Inclusion
- Healthy infants
Exclusion
- None Specified
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2004
Estimated Enrollment :
69274 Patients enrolled
Trial Details
Trial ID
NCT00090233
Start Date
January 1 2001
End Date
October 1 2004
Last Update
October 5 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.